Related by context. All words. (Click for frequent words.) 75 kidney urologic 74 CYT# potent vascular disrupting 74 taxane derivative 74 5 HT4 74 MKC# MT 73 INSPIRE Trial Phase III 73 Romidepsin 72 Enzastaurin 72 Pruvel TM 72 either acutely decompensated 72 potent topoisomerase II 72 oral dihydropyrimidine dehydrogenase DPD 72 Janus kinase 72 investigational humanized monoclonal antibody 71 GRNOPC1 contains 71 AKT inhibitor 71 candidate deforolimus 71 oral ghrelin agonist 71 protein tyrosine phosphatase 1B 71 NS5B polymerase 71 MAGE A3 ASCI 71 small molecule chemotherapeutic 71 JAK inhibitor 71 myelofibrosis polycythemia vera 71 LymphoStat B belimumab 71 PKC# 71 Zalypsis 71 peptidic compound 71 Teriflunomide 71 oral prodrug 71 Silodosin 71 hypoxia activated prodrug 71 secretory phospholipase A2 71 acadesine 71 novel VDA molecule 70 small molecule glucokinase 70 MKC# MKC# PP 70 cortisol synthesis 70 InSite Vision develops 70 Mg Usa 70 Pagoclone 70 candidates Azedra TM 70 IMiDs ® 70 Jodi Picoult Pocket FP 70 oral immunomodulatory 70 targets HGF FGFR 70 PEGylated Fab fragment 70 Fc fusion protein 70 familial amyloidotic polyneuropathy FAP 70 CYP#A# CYP#D# 70 Rigel R# 70 humanized therapeutic 70 MTP inhibitor 70 PI3K/Akt pathway inhibitor 70 coronary stent merged 70 Omacetaxine 70 accumulate preferentially 70 Safinamide 70 product platforms AZX# 70 DG# compounds targeting 70 CU NP 70 Darapladib 70 triggers apoptosis programmed 70 Bucindolol 70 oral antiviral 70 GW# [003] 70 chimeric monoclonal antibody 70 antibiotic candidate Ramoplanin 70 pan HDAC inhibitor 70 adenosine A2A 70 Telik logo TELINTRA 70 XL# anticancer compounds 70 mertansine 69 HCV NS5B polymerase 69 Initiates Phase II 69 Elotuzumab 69 INS# [001] 69 NS5b 69 RAF kinase 69 selective modulator 69 novel therapeutic antibodies 69 AAG geldanamycin analog 69 5 HT2A serotonin 69 non porcine pancreatic 69 Delta opioid receptor 69 receptor tyrosine kinase inhibitor 69 complement inhibitor eculizumab 69 pan BCR ABL 69 Mg Uk 69 Initiates Clinical Trial 69 pralatrexate injection folate analogue 69 M# rationally 69 metaglidasen 69 Immunotherapeutic 69 Methylnaltrexone 69 Completes Patient Enrollment 69 AEG# 69 KL4 Surfactant 69 platform HDL Mimetic 69 non nucleoside inhibitor 69 methylnaltrexone bromide 69 ATRA IV 69 Daclizumab 69 erlotinib Tarceva ® 69 Initiates Enrollment 69 EOquin TM phase 69 novel topoisomerase 69 HCV NS3 protease 69 oral JAK#/JAK# inhibitor 69 brivanib 69 Aflibercept 69 IMiDs R 69 PDX pralatrexate 69 metastatic colorectal 69 HGS ETR1 mapatumumab 69 class mGluR5 inhibitor 69 antibody MAb 69 FOLOTYN ® 69 Vidaza ® 69 Tofacitinib 69 huC# DM4 69 DP VPA 69 midstage clinical 68 docetaxel Taxotere ® 68 Aurora Kinase 68 Kuvan sapropterin dihydrochloride 68 RON Notch 68 virus HCV protease inhibitor 68 Epidermal Growth Factor Receptor 68 Sudhir Agrawal D.Phil 68 dasatinib Sprycel ® 68 including HGF ErbB3 68 Eculizumab 68 5 HT2A inverse 68 sodium glucose cotransporter 68 SinuNase ™ 68 commercialize apixaban 68 small molecule thrombopoietin 68 Meets Primary Endpoint 68 investigational monoclonal antibody 68 folate analogue metabolic 68 nilotinib Tasigna ® 68 dasatinib Sprycel 68 Epstein Barr Virus EBV 68 Enhanze TM Technology 68 MediGene focuses 68 selective kinase inhibitor 68 diarrhea predominant irritable 68 PORxin TM platforms 68 peripherally acting 68 Sapacitabine 68 Ribavirin causes 68 thalidomide Thalomid 68 inhibits dihydrofolate reductase 68 HuMax TAC 68 recurrent metastatic ovarian cancer 68 TKB# 68 Novel Oral 68 mTOR mammalian target 68 IAP inhibitor 68 Bayer HealthCare Onyx Pharmaceuticals 68 gastro intestinal inflammation 68 inflammatory PDE 68 CCR9 antagonist 68 pharmacogenomic translational research 68 Anti VEGF 68 INxin TM 68 aurora kinase 68 targeted radiotherapeutic 68 semi synthetic lipoglycopeptide 68 Provectus Pharmaceuticals specializes 68 Locked Nucleic Acid LNA 68 Tesetaxel 68 mecarbil 68 immunomodulatory properties 68 Alfacell proprietary ribonuclease 68 oral anti arrhythmic 68 ADP receptor antagonist 68 anticancer therapeutics 68 investigational oral anticoagulant 68 Factor Receptor 68 Degarelix 68 evaluating tivozanib 68 R sorafenib tablets 68 induced mucositis 68 sorafenib tablets 68 Ceflatonin R 68 advanced metastatic renal 68 delta opioid receptor 68 non nucleoside HCV 68 multicenter Phase II 68 selective A2A adenosine receptor 68 proteasome inhibitor 68 NuMimetic TM 68 label Lipofen R 68 neuronal nicotinic receptor NNR 68 agonistic human 68 R Saizen R 68 essential thrombocythemia ET 68 cyclin dependent kinase CDK 68 Vitamin D analogue 68 cetuximab Erbitux R 68 TNF Tumor Necrosis Factor 68 Aclidinium bromide 68 Crofelemer budesonide foam 68 orally administered inhibitor 67 Empatic ™ 67 Indibulin ZIO 67 Temsirolimus 67 targeted antifolate 67 cathepsin K inhibitor 67 TRIOLEX HE# APOPTONE HE# 67 Darinaparsin 67 CYP#A# isoenzyme 67 histone deacetylase HDAC 67 vinca alkaloid 67 IgG1 monoclonal antibody 67 biased ligand 67 including cyclosporine methotrexate 67 Fovea Pharmaceuticals subsidiary 67 liposomal formulation 67 Trandolapril 67 Aliskiren 67 Eraxis 67 itraconazole Sporanox 67 certain protein tyrosine 67 4 PDE4 enzyme 67 VEGFR2 inhibitor 67 Liprotamase 67 Vitrasert R 67 neuropathic pain spasticity 67 Azacitidine 67 vapreotide acetate 67 rusalatide acetate 67 peptibody 67 NS#/#A protease 67 JAK2 Inhibitor 67 Aviptadil 67 epothilones 67 targeted nucleotide prodrug 67 vesicular monoamine transporter 67 multi kinase inhibitor 67 Combination REOLYSIN R 67 Luteinizing Hormone Releasing Hormone 67 Multi Lineage Progenitor 67 targeting CD# 67 Successfully Completes Phase 67 OncoVex 67 small molecule tyrosine 67 Anidulafungin 67 NB S# strontium malonate 67 oral dual endothelin 67 Tß4 67 rHuPH# recombinant human 67 orally inhaled migraine 67 Factor VIIa 67 Hsp# Inhibitor 67 apoptosis inducer 67 highly selective inhibitor 67 immune modulator 67 Cannabinor 67 anti secretory 67 relapsed leukemia 67 microtubule inhibitor 67 LymphoStat B TM 67 novel orally administered 67 Peginterferon alfa 2b 67 NEBIDO VANTAS SUPPRELIN LA 67 Deforolimus 67 synthetic cannabinoid compounds 67 Pralatrexate 67 histone deacetylase inhibitor 67 Tezampanel 67 psoriasis inflammatory bowel 67 antiangiogenesis therapies 67 multicenter Phase III 67 Chrysalin r rusalatide acetate 67 toenail onychomycosis 67 NASH Huntington 67 ALTROPANE R 67 interferon alpha IFN 67 Solazed TM 67 Apaziquone 67 Initiate Phase 67 developing Bicifadine serotonin 67 oral Factor Xa 67 Peptide YY 67 MKC# 67 erlotinib Tarceva R 67 rheumatoid arthritis psoriatic arthritis 67 galiximab 67 gefitinib Iressa 67 fusion enhancers 67 Dacetuzumab 67 delivery polymer matrix 67 Transdermal Patch 67 TRANSDUR ® 67 Xcytrin R 67 AFREZZA TM 67 next generation URAT1 67 sulfonylhydrazine class 66 SAR# [002] 66 Panzem NCD 66 etanercept Enbrel 66 NPC 1C 66 Selzentry Celsentri 66 GERD migraine headaches 66 highly selective endothelin 66 Lenocta TM sodium stibogluconate 66 CYP#A# substrate 66 anti inflammatory NSAID 66 systemic juvenile idiopathic 66 brand ciclesonide HFA 66 acyclovir Lauriad R 66 Cariprazine 66 candidate oral AP# 66 induced macular edema 66 CysDisplay R 66 topical gel formulation 66 HQK 66 novel tubulin binding 66 Golimumab 66 undergoing elective percutaneous 66 Systemic lupus erythematosus SLE 66 pathophysiological effects 66 reverse vaccinology 66 Muraglitazar 66 CDK cyclin dependent 66 psoriasis Crohn disease 66 Afatinib 66 human IgG1 monoclonal 66 sunitinib Sutent ® 66 BCR ABL inhibitors 66 cromolyn sodium 66 Adenoviral 66 Elvitegravir 66 Initiates Phase III 66 infectious diseases autoimmune diseases 66 Schering Plough Remicade 66 novel peptide 66 BiTE R 66 cladribine Cladribine Tablets 66 vinorelbine tartrate 66 hormone LHRH antagonist 66 humanised monoclonal antibody 66 Tibotec Therapeutics division 66 cardio metabolic diseases 66 Tyrosine Kinase Inhibitor 66 Epratuzumab 66 Nasdaq MNKD focused 66 Ecallantide 66 Pruvel ™ 66 Receives Orphan Drug Designation 66 acetonide FA 66 5 HT4 agonist 66 evaluating picoplatin 66 Septin9 biomarker 66 Dementia Related Psychosis 66 candidates Azedra 66 visilizumab 66 vaginal candidiasis 66 LHRH receptor positive 66 Pazopanib 66 Archexin 66 Viprovex TM 66 lead molecular radiotherapeutic 66 mild vasodilator 66 cholesteryl ester transfer 66 phase Ib clinical 66 included exfoliative dermatitis 66 Atypical Hemolytic Uremic Syndrome 66 evaluating T DM1 66 novel immunomodulatory 66 factor TNF receptor 66 Anthrax Toxin 66 LAB CGRP 66 oral nucleoside analogue 66 Intravenous CP 66 Cardium Therapeutics TM 66 small molecule VR1 66 5 fluorouracil leucovorin 66 dyslipidemia hypertension diabetes 66 BCG refractory carcinoma 66 SinuNase TM 66 specific lectin receptors 66 AVAPRO 66 memantine HCl 66 Randomized Phase II 66 staphylococcal vaccine 66 lexidronam injection 66 Personalized Immunotherapy 66 potent antiproliferative 66 multiple sclerosis psoriasis 66 Atripla combines 66 products MKC# PP 66 Progressive Multifocal Leukoencephalopathy 66 bevacizumab Avastin R 66 investigational integrase inhibitor 66 #beta HSD 1 66 Zollinger Ellison Syndrome 66 Bosutinib 66 SUTENT ® 66 constipation predominant irritable bowel 66 GVAX ® 66 herpes zoster shingles 66 Combivir Kivexa 66 interferon gamma 1b 66 oncolytic virus therapies 66 Achieves Primary Endpoint 66 TLR9 agonist 66 Tyrima 66 Cetrorelix pamoate 66 generation camptothecin analogue 66 NU# direct 66 specific CCR9 antagonist 66 Crizotinib 66 lupus hepatitis C 66 anionic backbone 66 Viagra Soft Cialis Soft 66 R lenalidomide 66 PNP inhibitor 66 Files IND 66 Phase 1b clinical trials 66 faropenem medoxomil 66 TRACON Pharmaceuticals 66 optical biosensors 66 personalized cellular immunotherapy 66 immune modulatory 66 Ridaforolimus 66 Antigen Specific 66 anti amnesic 66 Solazed ™ 66 Aganocide ® 66 p# inhibitor 66 Phase Ib IIa 66 hypoxia selective 66 phase III isavuconazole 66 TO AVOID PREGNANCY WHILE 66 histone deacetylase inhibitors 66 AN# topical anti 66 therapeutic monoclonal antibody 66 Friedreich Ataxia FRDA 66 hepatitis C lupus 66 estrogen receptor beta agonist 66 Onconase 66 IMPDH inhibitor 66 selective estrogen receptor modulator 66 Albuferon albinterferon alfa 2b 66 lung pancreatic 66 Therapeutic Competitors Companies 66 small molecule Hedgehog 66 RTP #i 66 Anthracycline 66 selective inverse agonist 66 Randomized Phase 66 psoriasis rheumatoid arthritis 66 allogeneic cell 66 HepDirect prodrug 66 DNA methyltransferase inhibitors 66 imatinib Gleevec ® 66 Merck OSI Pharmaceuticals 65 Pegloticase 65 Kinase Inhibitor 65 prokinetic agent 65 cyclin dependent kinase inhibitor 65 non cirrhotic portal 65 XL# XL# 65 immunologic diseases 65 recombinant PSMA vaccine 65 lipoglycopeptide 65 treat benign prostatic 65 docetaxel Taxotere R 65 XP# XP# 65 Blinatumomab 65 UCB www.ucb group.com 65 MetroGel 65 HYVISC ® treatment 65 sapacitabine CYC# 65 commercialize CorMedix drug 65 thetreatment 65 EZN 65 humanized monoclonal 65 dihydroergotamine 65 RAS MAPK pathway 65 FDA APPROVES 65 Complicated Skin 65 antisense inhibitors 65 includes TOLAMBA TM 65 pentadentate logo R 65 delivers fluocinolone acetonide FA 65 candidate CRLX# 65 hypereosinophilic syndrome 65 R MSCRAMM 65 CEQ# 65 Novolimus 65 Homspera TM 65 Shows Promise Against 65 soluble tumor necrosis 65 enhance ApoA 65 syndrome gastroesophageal reflux 65 Cloretazine R 65 Nexavar ® 65 fosbretabulin 65 treat refractory angina 65 hypoxia inducible factor 65 patented Aganocide compounds 65 alemtuzumab MS 65 Aplidin R 65 Locked Nucleic Acid 65 Myolimus 65 Aeolus Pharmaceuticals Announces 65 humanized anti 65 Kimchee Kronicles 65 Panzem R 65 selective phosphodiesterase 65 antisense therapies 65 Monoclonal antibody 65 potent cytotoxic 65 CCR5 mAb 65 human antibody therapeutics 65 Refractory Hodgkin Lymphoma 65 proprietary biomaterials 65 Oragens TM 65 migraine headaches neuropathic pain 65 Pharma Merck Serono 65 Trastuzumab DM1 65 development peramivir neuraminidase 65 Aganocide 65 including eniluracil ADH 65 mda 7 65 Glycopyrrolate 65 TLR7 agonist 65 IMiDs ® compound 65 ALS #-# 65 Randomized Double blind 65 unique alkylating agent 65 reslizumab 65 oral proteasome inhibitor 65 Demonstrates Positive 65 Presents Positive 65 superparamagnetic iron oxide nanoparticles 65 using VIAdel TM 65 IMPACS R 65 CYT# vascular disrupting 65 oral transdermal 65 Initiates Clinical 65 novel emulsion formulation 65 Vidaza R 65 mTOR kinase 65 Laquinimod 65 IAP inhibitors 65 P#X# antagonist 65 Begins Dosing 65 antibiofilm 65 CD# monoclonal antibody 65 Orally administered 65 adrenergic regulation 65 Gleevec resistant 65 Rum Diary written 65 Systemic Delivery 65 atypical Hemolytic Uremic Syndrome 65 HSP# inhibitor 65 Squalamine 65 Pertuzumab 65 interleukin IL -# 65 Prodarsan R 65 Arno Therapeutics 65 allosteric modulator PAM 65 leukotriene pathway 65 gabapentin Neurontin 65 novel immunotherapies 65 Dalbavancin 65 selective androgen receptor modulators 65 ZACTIMA 65 MSCRAMM ® 65 MCSP respectively 65 commercializing oxidized glutathione 65 Budesonide foam crofelemer 65 canagliflozin 65 Initiate Clinical Trial 65 treat chronic sinusitis 65 delta gamma agonist 65 Serostim R 65 adecatumumab MT# 65 Rilonacept 65 Pitavastatin 65 Receives Approvable Letter 65 4SC AG ISIN DE# 65 t2cure GmbH 65 Medidur TM FA 65 Emtriva Viread 65 signal transduction inhibitor 65 triciribine phosphate monohydrate 65 Angiocept 65 tramiprosate Alzhemed TM 65 Deferiprone 65 structure infections ABSSSI 65 dyskinesia PD LID 65 Vytorin combines 65 Cotara ® 65 Annamycin 65 Romiplostim 65 CTAP# Capsules 65 selective immunoproteasome inhibitor 65 signal detection CTSD 65 Pancreate 65 Phase III Pivotal 65 PRN FDA Approves 65 Solzira ™ 65 receptor inhibitor 65 relapsing remitting MS RRMS 65 influenza BCX# purine nucleoside 65 demonstrated antitumor activity 65 chemically modified tetracyclines 65 Dean Koontz Bantam FP 65 dimebon latrepirdine 65 Talabostat 65 vidofludimus 65 Syncria albiglutide 65 CFTR corrector 65 candidate AQ4N 65 include Healive TM 65 injectable investigational 65 prescribed proton pump 65 Elacytarabine 65 AQD class 65 Kahalalide F 65 HepDirect R 65 Second Pivotal Phase 65 alkylating 65 camptothecin CPT 65 targeted anticancer biopharmaceuticals 65 ALN TTR# 65 ABLYNX 65 Apixaban 65 HCV SPRINT 65 sorafenib Nexavar R 65 TLK# 65 GTC recombinant human 65 HCV protease inhibitors 65 6 sulfatase 65 Protein Kinase C 65 PDE4 inhibitor 65 ACTIQ ® 65 Oracea TM 65 solid tumors ZYBRESTAT 65 combining voreloxin 65 aripiprazole Abilify 65 Namenda Memantine HCl 65 Leukopenia neutropenia 65 modified glutathione analog 65 selective antagonist 65 rALLy clinical trial 65 intranasal formulation 65 cardio renal 65 Cerebral Amyloid Angiopathy 65 TNF alpha selectively neutralizing 65 Submits NDA 65 DEB# 65 multitargeted 65 OMP #R# 65 histone deacetylase HDAC inhibitors 65 LPA1 65 NP2 Enkephalin 65 Obatoclax 65 atypical hemolytic uremic syndrome 65 lucinactant 65 ® bortezomib 65 Azixa MPC 65 novel antibody therapeutics 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 ENMD # 65 Completes Enrollment 65 cisplatin resistant 65 pain palliation 65 Sphingomab TM 65 Serostim ® 65 Olmesartan 65 adalimumab Humira 65 GSK '# 65 Initiates Dosing 65 factor Xa inhibitor 65 2 inhibitor CYT# 65 Dose Ranging Study 65 Sodium oxybate 65 engineered proteases 65 pan histone deacetylase 65 telomerase therapeutic 65 vinca alkaloids 65 Oral NKTR 65 MAbs targeting 65 treat secondary hyperparathyroidism 65 Desvenlafaxine 65 delay bone metastases 65 Mipomersen 65 Endologix Powerlink System 64 engineered RAP peptides 64 Darinaparsin ZIO 64 gastrointestinal stromal 64 Polymerase Inhibitor 64 identify protein biomarkers 64 Peroxisome Proliferator Activated Receptor 64 somatostatin analogue 64 anaphylactic reactions bronchospasm 64 Humanized Anti 64 Acute Exacerbations 64 By JENNIFER LEARN 64 Spiegelmers R 64 HIV treatments Reyataz 64 receptor modulators 64 albiglutide currently 64 RhuDex R 64 Val HeFT 64 androgen receptor antagonist 64 BiTE ® 64 Plasmin 64 endothelin receptor 64 HCD# [002] 64 oral Hsp# inhibitor 64 calcitonin gene related 64 HDAC Inhibitor 64 PLX STROKE targeting 64 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 64 alkylating agent 64 gemcitabine Gemzar ® 64 Amgen Neulasta R 64 Strep Staph 64 immunotoxin 64 Albuferon TM 64 mGluR2 NAM 64 Ataluren 64 nucleotide analog 64 purinergic receptors P#X# 64 Hodgkin lymphoma HL 64 myeloproliferative disorders 64 Inhaled nitric oxide 64 YONDELIS 64 Imatinib mesylate 64 M2 subunit 64 activate SIRT1 64 Prochymal TM 64 denileukin diftitox 64 myocardial infarction ventricular fibrillation 64 Veronate R 64 treat chronic rhinosinusitis 64 Presents Preclinical Data 64 renin inhibitors 64 develop HBV reactivation 64 EVIZON TM 64 Warner Chilcott Actonel 64 Small Modular SMIP 64 anticoagulant reversing agent 64 CD4 monoclonal antibody 64 antimitotic 64 EGFR HER2 64 MitoQ 64 Bucindolol Based 64 selective estrogen receptor modulators 64 Study Evaluating 64 RhuDex ® 64 Nasdaq IDIX biopharmaceutical 64 Prolongs Survival 64 IMA# 64 HuCNS SC ® 64 endoluminal stent graft 64 oral antiplatelet agent 64 Phase III Clinical Trial 64 Shigatoxin producing E. coli 64 designed natriuretic peptide 64 psychiatric disorders ATI 64 Apoptone HE# 64 Angiotensin Converting Enzyme 64 Intravenous immunoglobulin 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 GSK# [002] 64 Verstovsek 64 Factor Xa inhibitor 64 oral picoplatin 64 zoledronic acid Reclast 64 investigational pharmacologically unique 64 acute mania 64 candidate custirsen 64 Lisofylline LSF 64 polycythemia vera PV 64 Presents Preclinical 64 antiplatelet compound 64 Reports Preclinical Data 64 nucleoside analog 64 FUSILEV enhances 64 histone deacetylase HDAC inhibitor 64 topical non steroidal 64 BioNumerik 64 novel chimeric natriuretic 64 INTEGRILIN R 64 XOMA 3AB biodefense 64 pharmacokinetic interactions 64 Curaxin 64 immuno modulatory 64 PRT# 64 ELADUR ™ 64 sorafenib Nexavar 64 aflibercept VEGF Trap 64 Aclidinium 64 JAK2 inhibitor 64 benign prostatic hypertrophy BPH 64 GPR# agonist 64 defensin mimetic antibiotic 64 Smac mimetics 64 2 methoxyestradiol 64 relapsed MM 64 novel antimitotic agent 64 tetracycline antibiotic 64 refractory chronic lymphocytic 64 SPRYCEL ® 64 trastuzumab DM1 T DM1 64 Staphylococcus aureus Immune Globulin 64 Sphingomab 64 leading oral taxane 64 receptor inhibiting monoclonal 64 Naive Patients 64 Ofatumumab 64 virosome 64 SPL# Gel vaginal microbicide 64 Onalta 64 generation purine nucleoside 64 Spiegelmer ® 64 cilengitide 64 Excellarate TM 64 Elagolix 64 infectious diseases autoimmune 64 Oragens R 64 non peptidic protease 64 CEL SCI Phase III 64 inhaled formulations 64 selective inhibition 64 membranous nephritis 64 RNA antagonists 64 Monoclonal 64 investigational oral inhibitor 64 Am J Obstet 64 dependent kinase inhibitor 64 chronic myeloid 64 cardiac myosin activator omecamtiv 64 dopamine D2 64 imatinib Gleevec 64 immunotherapeutic agent 64 nilotinib Tasigna 64 Denufosol 64 Tumor necrosis factor 64 MEK inhibitor 64 Augment TM 64 Fx #A 64 PEGylated docetaxel 64 Zolpimist ™ 64 systemic anaplastic large 64 Phase IIb Trial 64 anti miRs antisense oligonucleotide 64 Aflibercept VEGF Trap 64 Ostabolin C TM 64 Lenocta 64 Cardiotoxicity 64 Inotek Pharmaceuticals Corporation 64 Pathway Inhibitor 64 Dapagliflozin 64 Initiates Phase 64 hyperplasia BPH 64 thymidylate synthase TS 64 monoclonal antibody MAb 64 Xanafide 64 Phase 2b Clinical Trial 64 antibody blinatumomab MT#/MEDI-# 64 Initiated Phase 64 topically applied SEPA 64 Preclinical Study 64 Vidaza azacitidine 64 Vidofludimus 64 CTAP# 64 AV HALT 64 Nanobody 64 alpha#beta# integrin 64 Aciphex R 64 GRN# 64 Drug Candidate 64 ALK inhibitors 64 IL# PE#QQR 64 Plaquenil 64 Akt inhibitor 64 OMP #M# 64 Human cl 64 mitotic kinesin 64 developing Surfactant Replacement 64 Panzem R NCD 64 dermatology therapies 64 TÎ ² 4 64 Pancreas Cancer Vaccine 64 HCV RNA polymerase 64 Mylan Receives Approval 64 Alzheimer disease cognitive impairment 64 Phase 2b Study 64 Oral Fingolimod 64 Darinaparsin Zinapar TM 64 HCl PEPCID ® famotidine 64 platinum chemotherapeutic 64 ALN PCS 64 EXPLORE Xa 64 dihydrofolate reductase 64 Drug Shows Promise 64 selective A1 adenosine 64 oral deforolimus 64 NYSE PFE Exelon Rivastigmine 64 Pivotal Phase III 64 combines bupropion 64 Treatment Shows Promise 64 polyneuropathy HIV DSP 64 Severe Sepsis 64 ELADUR TM 64 Familial Adenomatous Polyposis FAP 64 anti botulism antibody 64 TM Aganocide 64 Pharmacokinetics PK 64 Phase 2b Trial 64 anti atherothrombotic 64 monoclonal antibody therapeutics 64 Cytotoxic 64 stable nucleic acid 64 retinal vein occlusion induced 64 oral JAK1 64 bortezomib Velcade 64 EGFr expressing metastatic colorectal 64 ARRY # 64 Kosan dependence 64 Commences Phase 64 TTR amyloidosis 64 Cathepsin B 64 investigational oral antiplatelet 64 reversible inhibitors 64 humanized interleukin 6 64 Vicriviroc 64 INDIVIDUALLY AND AS 64 Major Depressive Disorder MDD 64 torsemide ER 64 PSMA ADC 64 PU H# 64 Horizant ™ 64 attach auristatin 64 ribonucleotide reductase clinically validated 64 Acrongenomics brings 64 prostate cancer benign prostatic 64 platforms GVAX 64 AAG KOS 64 reversible inhibitor 64 rNAPc2 64 TRANSDUR ™ 64 Tipranavir 64 Aztreonam lysine 64 atrial fibrillation budiodarone ATI 64 oropharyngeal candidiasis OPC 64 polysaccharide polymer 64 USP Tablets PEPCID 64 constipation OIC 64 mGluR5 NAM 64 Oxytrex TM 64 alpha#beta# 64 particularly SANCTURA XR 64 Trial Evaluating 64 delivered RNAi therapeutic 64 inhibit oxidative stress 64 alpha TNFa 64 hyperphenylalaninemia HPA due 64 molecular imaging radiopharmaceutical 64 oncologic diseases 64 Belimumab 64 product platforms GVAX 64 imexon 64 Parnate 64 ALN HPN 64 Vascular Endothelial Growth 64 Selective Inhibitor 64 Nereus Pharmaceuticals 64 CD3 monoclonal antibody 64 refractory gout 64 iloprost synthetic compound 64 mGluR2 positive 64 selectively inhibit replication 64 Hexvix ® 64 hereditary emphysema 64 AVI antisense 64 Associated Adipose Redistribution 64 Demonstrates Efficacy 64 radiation sensitizer 64 trial evaluating PRX# 64 overactive bladder AA# 64 hyaluronidase enzyme 64 Morria Biopharmaceuticals Plc 64 vascular disrupting agents 64 IL-#/# 64 metabolism viral replication 64 proliferative diseases 64 HuCAL PLATINUM ® CysDisplay